Peer Reviewed
Therapeutics clinic

Changes to PBS criteria for testosterone prescribing

Rob Mclachlan
Abstract
Recent changes to the criteria for PBS-subsidised testosterone prescriptions have caused some confusion. This article explains what these changes are and how they will affect your patients.
Key Points

    In April 2015, the Pharmaceutical Benefits Advisory Committee (PBAC) announced new criteria for patient eligibility for the prescription of testosterone subsidised by the Pharmaceutical Benefits Scheme (PBS). Feedback to Andrology Australia from doctors and patients already taking or about to start taking testosterone has indicated a level of community concern over these new rules.

    Picture credit: © Phanie/Voisin/Diomedia.com

Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?